Source: European Heart Journal. Conference titles: European Society of Cardiology Congress/ESC. Unidades: FM, FCF
Subjects: LIPÍDEOS, NANOPARTÍCULAS, ARTERIOSCLEROSE
ABNT
MENEGHINI, Bianca Correa et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. European Heart Journal. Oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 28 ago. 2024. , 2018APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. European Heart Journal. Oxford: Faculdade de Medicina, Universidade de São Paulo.NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. European Heart Journal. 2018 ; 39 804 res. P3792.[citado 2024 ago. 28 ]Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. European Heart Journal. 2018 ; 39 804 res. P3792.[citado 2024 ago. 28 ]